{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:22:23Z","timestamp":1789611743505,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jss.2019.09.072","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T08:38:05Z","timestamp":1573029485000},"page":"211-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Validation of the Prognostic Significance of the Prognostic Stage Group According to the Eighth Edition of American Cancer Joint Committee on Cancer Staging System in Triple-Negative Breast Cancer: An Analysis From Surveillance, Epidemiology, and End Results 18 Database"],"prefix":"10.1016","volume":"247","author":[{"given":"Shi-Ping","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Sen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Xia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Gui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2019.09.072_bib1","series-title":"AJCC Cancer Staging Manual","first-page":"589","year":"2017"},{"key":"10.1016\/j.jss.2019.09.072_bib2","series-title":"AJCC Cancer Staging Manual","year":"2017"},{"key":"10.1016\/j.jss.2019.09.072_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/jamaoncol.2017.4298","article-title":"Validation study of the American Joint Committee on Cancer eighth edition prognostic stage compared with the anatomic stage in breast cancer","volume":"4","author":"Weiss","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jss.2019.09.072_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.breast.2017.10.011","article-title":"Evaluation of the prognostic stage in the 8th edition of the American Joint Committee on Cancer in locally advanced breast cancer: an analysis based on SEER 18 database","volume":"37","author":"Wang","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.jss.2019.09.072_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.21147\/j.issn.1000-9604.2017.04.08","article-title":"A retrospective prognostic evaluation analysis using the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system for luminal A breast cancer","volume":"29","author":"Ye","year":"2017","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.jss.2019.09.072_bib6","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.4103\/0366-6999.211896","article-title":"A retrospective survival analysis of anatomic and prognostic stage group based on the American Joint Committee on Cancer 8th edition cancer staging manual in luminal B human epidermal growth factor receptor 2-negative breast cancer","volume":"130","author":"Xu","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jss.2019.09.072_bib7","first-page":"4615","article-title":"The prognostic value of the 8th edition of the American Joint Committee on Cancer (AJCC) staging system in HER2-enriched subtype breast cancer, a retrospective analysis","volume":"37","author":"Zhou","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jss.2019.09.072_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.14740\/wjon1039e","article-title":"A retrospective analysis of clinical utility of AJCC 8th edition cancer staging system for breast cancer","volume":"8","author":"Hu","year":"2017","journal-title":"World J Oncol"},{"key":"10.1016\/j.jss.2019.09.072_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10549-018-4682-5","article-title":"A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer","volume":"169","author":"Lee","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jss.2019.09.072_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10549-018-4832-9","article-title":"Validation of the newly proposed American Joint Committee on Cancer (AJCC) breast cancer prognostic staging group and proposing a new staging system using the National Cancer Database","volume":"171","author":"Li","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jss.2019.09.072_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10549-017-4577-x","article-title":"Validation of the 8th AJCC prognostic staging system for breast cancer in a population-based setting","volume":"168","author":"Abdel-Rahman","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jss.2019.09.072_bib12","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/S0140-6736(16)32454-0","article-title":"Molecular alterations in triple-negative breast cancer\u2014the road to new treatment strategies","volume":"389","author":"Denkert","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jss.2019.09.072_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-016-4059-6","article-title":"Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer","volume":"161","author":"Li","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jss.2019.09.072_bib14","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer","volume":"26","author":"Liedtke","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2019.09.072_bib15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jamcollsurg.2011.09.018","article-title":"Is the new seventh AJCC\/UICC staging system appropriate for patients with gastric cancer?","volume":"214","author":"Yoon","year":"2012","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jss.2019.09.072_bib16","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1245\/s10434-011-2206-1","article-title":"Evaluation of the seventh edition of American Joint Committee on Cancer TNM staging system for gastric cancer: results from a Chinese monoinstitutional study","volume":"19","author":"Sun","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2019.09.072_bib17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/SLA.0b013e31821111b5","article-title":"Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer\/American Joint Cancer Committee staging system","volume":"253","author":"Gertler","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2019.09.072_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2012.44.4315","article-title":"Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution","volume":"31","author":"Reim","year":"2013","journal-title":"J Clin Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.jss.2019.09.072_bib19","doi-asserted-by":"crossref","first-page":"S278","DOI":"10.1245\/s10434-011-1649-8","article-title":"Further expansion of the AJCC\/UICC breast cancer staging system to encompass unique problems in the developing world","volume":"18","author":"Murthy","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2019.09.072_bib20","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1200\/JCO.2015.61.1459","article-title":"Use of biomarkers to guide decisions on systemic therapy for women with metastatic breast cancer: American Society of Clinical Oncology Clinical Practice Guideline","volume":"33","author":"Van Poznak","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2019.09.072_bib21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.clbc.2011.05.003","article-title":"Recommendation to revise the AJCC\/UICC breast cancer staging system for inclusion of proven prognostic factors: ER\/PR receptor status and HER2 neu","volume":"11","author":"Murthy","year":"2011","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.jss.2019.09.072_bib22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","volume":"378","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jss.2019.09.072_bib23","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2019.09.072_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00129039-200203000-00007","article-title":"Comparison of HER-2\/neu oncogene amplification detected by fluorescence in situ hybridization in lobular and ductal breast cancer","volume":"10","author":"Rosenthal","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.jss.2019.09.072_bib25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1634\/theoncologist.2008-0230","article-title":"The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine","volume":"14","author":"Ross","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.jss.2019.09.072_bib26","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jamaoncol.2015.2286","article-title":"The evolving landscape of HER2 targeting in breast cancer","volume":"1","author":"Moasser","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jss.2019.09.072_bib27","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.5858\/arpa.2013-0435-OA","article-title":"Histologic grade remains a prognostic factor for breast cancer regardless of the number of positive lymph nodes and tumor size: a study of 161 708 cases of breast cancer from the SEER Program","volume":"138","author":"Schwartz","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jss.2019.09.072_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/bcr2607","article-title":"Breast cancer prognostic classification in the molecular era: the role of histological grade","volume":"12","author":"Rakha","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.jss.2019.09.072_bib29","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1245\/s10434-017-6009-x","article-title":"Bioscore: a staging system for breast cancer patients that reflects the prognostic significance of underlying tumor biology","volume":"24","author":"Mittendorf","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2019.09.072_bib30","article-title":"The prognostic value of the AJCC 8th edition staging system for patients undergoing neoadjuvant chemotherapy for breast cancer","author":"Kantor","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2019.09.072_bib31","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1245\/s10434-018-7068-3","article-title":"The prognostic significance of the oncotype DX recurrence score in TNM estrogen receptor-positive HER2-negative breast cancer based on the prognostic stage in the updated AJCC 8th edition","volume":"26","author":"Wang","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2019.09.072_bib32","first-page":"290","article-title":"Breast cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Giuliano","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jss.2019.09.072_bib33","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480419307413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480419307413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:46:28Z","timestamp":1758379588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480419307413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":33,"alternative-id":["S0022480419307413"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2019.09.072","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of the Prognostic Significance of the Prognostic Stage Group According to the Eighth Edition of American Cancer Joint Committee on Cancer Staging System in Triple-Negative Breast Cancer: An Analysis From Surveillance, Epidemiology, and End Results 18 Database","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2019.09.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}